COVID-19-Induced Hyperleucocytosis in Chronic Lymphocytic Leukaemia

COVID-19-Induced Hyperleucocytosis in Chronic Lymphocytic Leukaemia

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus responsible for the current global pandemic, coronavirus disease 2019 (COVID-19). COVID-19 usually presents with respiratory symptoms but can affect multiple organ systems. A wide spectrum of complications can occur...

Full description

Bibliographic Details
Main Authors: Balraj Singh, Sarah Ayad, Parminder Kaur, Ro-Jay Reid, Sachin Gupta, Michael Maroules
Format: Article
Language:English
Published: SMC MEDIA SRL 2021-03-01
Series:European Journal of Case Reports in Internal Medicine
Subjects:
covid-19
sars-cov-2
cll
chronic lymphocytic leukaemia
lymphocytosis
leucocytosis
lymphopenia
Online Access:https://www.ejcrim.com/index.php/EJCRIM/article/view/2348
Description
Summary:Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus responsible for the current global pandemic, coronavirus disease 2019 (COVID-19). COVID-19 usually presents with respiratory symptoms but can affect multiple organ systems. A wide spectrum of complications can occur depending upon the comorbidities of patients. There is limited literature available regarding the presentation and outcome of COVID-19 in chronic lymphocytic leukaemia (CLL) patients. We report 2 cases of COVID-19-induced hyperleucocytosis (WBC count >100,000/?l) in CLL patients.
ISSN:2284-2594

Similar Items